Sexually Transmitted Infections Treatment Guidelines, 2021
Open accessThe DOI matches its Crossref record; 1,459 of the 1,505 references it cites were found in a registry or an index; 371 of the 802 sources its claims cite were checked for support.
Abstract
These guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease; 3) alternative treatment options for bacterial vaginosis; 4) management of Mycoplasma genitalium; 5) human papillomavirus vaccine recommendations and counseling messages; 6) expanded risk factors for syphilis testing among pregnant women; 7) one-time testing for hepatitis C infection; 8) evaluation of men who have sex with men after sexual assault; and 9) two-step testing for serologic diagnosis of genital herpes simplex virus. Physicians and other health care providers can use these guidelines to assist in prevention and treatment of STIs.
Overview
CoChat Summary
TL;DR
These CDC guidelines update the 2015 STI treatment recommendations after expert consultation and systematic literature review, covering prevention, diagnosis, treatment, and special populations. They include updated guidance for gonorrhea, chlamydia, trichomoniasis, pelvic inflammatory disease, bacterial vaginosis, *Mycoplasma genitalium*, HPV vaccination, syphilis screening in pregnancy, hepatitis C testing, sexual assault evaluation, and HSV serology.
Key findings
- Congenital syphilis in the United States increased from 8.4 to 48.5 cases per 100,000 births during 2012–2019, a 477.4% increase.
- Three randomized controlled trials in sub-Saharan Africa found male circumcision reduced HIV acquisition among men by 50%–60%; HPTN 052 found ART for the infected partner decreased HIV transmission to uninfected heterosexual partners by 96%.
- Doxycycline postexposure prophylaxis after unprotected anal sex among MSM and transgender women reduced incident chlamydia and syphilis by 70% and 73%, respectively, but had no effect on gonorrhea.
- Expedited partner therapy trials showed reductions in chlamydia prevalence at follow-up of approximately 20% and gonorrhea of approximately 50%.
Methods
- CDC staff worked with subject matter experts to identify key questions and conduct systematic MEDLINE-based literature reviews for each section of the 2015 guidelines, focused on microbiologic eradication, symptom alleviation, prevention of sequelae, and prevention of transmission.
- Experts presented literature assessments at an in-person meeting in Atlanta, Georgia, June 11–14, 2019; evidence was rated high, medium, or low using USPSTF-style ratings, and draft recommendations underwent peer review and a public webinar before finalization.
- Recommendations for HIV, hepatitis C, cervical cancer screening, STI screening in pregnancy, HPV testing, and HAV/HBV vaccination were developed after reviewing existing published recommendations.
Limitations
- The paper states these guidelines are “a source of clinical guidance rather than prescriptive standards” and that providers should consider each person’s clinical circumstances and local disease prevalence.
- The paper states several evidence gaps, including limited data on doxycycline STI prophylaxis, no long-term data on STI postexposure prophylaxis effects on antimicrobial resistance and the microbiome, and insufficient data to recommend routine anal cancer screening with anal cytology.
- Evident from the text: many recommendations, especially for syphilis treatment, rely on decades of clinical experience and observational data rather than randomized controlled trials; the document is a broad guideline rather than a single primary study with a defined sample or comparator.
Model-written summary of a shortened version of the paper’s full text (it is longer than we read). Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
221 Valid · 41 Not valid · 158 Not checked · 82 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Adherence can be low (48), and prevention of HIV infection, especially among women, has not been demonstrated (47,49).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Clinical Prevention Guidance > Primary Prevention Methods
What the sources say
- Disputedcites [47] Abdool Karim Q, Abdool Karim SS, Frohlich JA,; CAPRISA 004 Trial Group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329: 1168– 74. Erratum in: Science 2011;333:524. 10.1126/science.1193748 20643915 PMC3001187 sourceExperimental — accuracy not yet measured
The Results (‘HIV incidence and effectiveness’; page unavailable) report 5.6 HIV infections per 100 women-years with tenofovir gel versus 9.1 with placebo (p=0.017) in a trial of women. The Discussion states that the gel reduced HIV infection by an estimated 39%. Although the authors call for corroboration, their findings directly contradict the claim that prevention had not been demonstrated. (LLM, conf=0.91)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [49] Delany-Moretlwe S, Lombard C, Baron D, Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2018; 18: 1241– 50. 10.1016/S1473-3099(18)30428-6 30507409 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In addition, nontreponemal test titers might decrease more slowly for persons previously treated for syphilis (594,595).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Primary and Secondary Syphilis
What the sources say
- Could not verifycites [594] Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 2007; 83: 97– 101. 10.1136/sti.2006.021402 16943224 PMC2598600 sourceExperimental — accuracy not yet measured
The Results (page unavailable) mention a history of syphilis infection, but do not compare titre declines by prior treatment history. The paper compares response times by HIV status and syphilis stage; searches for prior treatment and serological response found no passage addressing whether previously treated patients’ titres decline more slowly. (LLM, conf=0.76)
- Disputedcites [595] Seña AC, Wolff M, Martin DH, Predictors of serological cure and serofast state after treatment in HIV-negative persons with early syphilis. Clin Infect Dis 2011; 53: 1092– 9. 10.1093/cid/cir671 21998287 PMC3205200 sourceExperimental — accuracy not yet measured
In Characteristics Associated With Serological Cure (page unavailable), the paper reports that a history of syphilis was not significantly associated with serological cure; the Discussion likewise says it found no association between history of syphilis and serological response. It mentions a prior study finding less seroreversion after repeat infection, but that is not a finding that titers decrease more slowly in previously treated persons. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that use of additional doses of benzathine penicillin G, amoxicillin, or other antibiotics do not enhance efficacy of this recommended regimen when used to treat primary and secondary syphilis, regardless of HIV status (591–593).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Primary and Secondary Syphilis
What the sources say
- Not checked — no full text of the sourcecites [591] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) explicitly says that, among HIV-infected patients with early syphilis, one dose of benzathine penicillin G was inferior to three weekly doses for serological response at 12 months—the opposite of the claim about additional doses. The study excluded patients who received other antibiotics, so it does not establish whether adding amoxicillin or other antibiotics helps; it also does not establish the claim regardless of HIV status. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Factors Associated With Treatment Response section reports similar responses with one versus multiple BPG doses in HIV-infected people with early syphilis. The study does not establish that adding amoxicillin or other antibiotics to the recommended regimen offers no benefit: its “other” regimens were grouped together and could be alternatives rather than additions. Nor do its findings establish the result regardless of HIV status; the Discussion also notes limited power for people with advanced immunosuppression. Page numbers were not available in our copy. (LLM, conf=0.89)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that additional doses of benzathine penicillin G, amoxicillin, or other antibiotics in early latent syphilis do not enhance efficacy, regardless of HIV status (592,593,609).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Latent Syphilis
What the sources say
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Results report that three weekly doses of benzathine penicillin G were associated with a higher serological response than one dose in patients with HIV and early syphilis; the Discussion explicitly calls the one-dose regimen inferior at 12 months. This contradicts the claim that additional doses do not enhance efficacy. The study did not test additional amoxicillin or other antibiotics, or patients without HIV. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Results report similar treatment responses with one versus multiple BPG doses in HIV-infected people with early syphilis. However, the Data Analysis and Definitions section says syphilis stage was not consistently captured, and the study did not establish the claim specifically for early latent syphilis, amoxicillin or other added antibiotics, or people without HIV. The Discussion further limits its conclusion to patients with preserved CD4 counts and low viral loads. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [609] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that additional doses of benzathine penicillin G, amoxicillin, or other antibiotics in primary and secondary syphilis among persons with HIV infection do not result in enhanced efficacy (592,593,609).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Syphilis Among Persons with HIV Infection
What the sources say
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Results report that three weekly doses of benzathine penicillin G were independently associated with a higher serological response than one dose in HIV-infected patients with early syphilis. The Discussion says the subgroup results generally favored three doses, except among patients presenting with primary syphilis; the study did not test additional amoxicillin or other antibiotics. These findings contradict the cited sentence’s blanket claim of no enhanced efficacy. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Results (Factors Associated With Treatment Response; page not provided) found similar serologic responses with one versus multiple BPG doses in HIV-infected people with early syphilis. It also found no improved response for a pooled “other” regimen group, but the Data Analysis and Definitions section says that group combined penicillin derivatives used alone or with BPG and non-penicillin antibiotics. The paper therefore does not establish the claim specifically for additional amoxicillin or each other antibiotic. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [609] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
264 more claims · 126 with their cited sources checked
Create a free account to see all 502 claims and to verify the 10 references still open.
- Probably not a substantial claim. 72
- It may state two separate claims as one. 188
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and a reduction of half the risk of perinatal death (RR, 0.50; 95% CI: 0.33-0.84) (5) as long as treatment for GS been administered 30 days before delivery 5.”
From Efectividad del tratamiento de la sífilis gestacional en el último trimestre sobre la incidencia de sífilis congénita: revisión sistemática y metanálisis (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The strategy of early diagnosis with rapid tests and immediate treatment (on the same day) with at least one dose of benzathine penicillin leads to a reduction of about 98% in the incidence of CS (relative risk (RR), 0.02; 95% confidence interval (CI: 0.00-0.18)”
From Efectividad del tratamiento de la sífilis gestacional en el último trimestre sobre la incidencia de sífilis congénita: revisión sistemática y metanálisis (2025) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Congenital Syphilis
“a serum quantitative nontreponemal serologic titer that is fourfold§ (or greater) higher than the mother’s titer at delivery (e.g., maternal titer = 1:2, neonatal titer ≥1:8 or maternal titer = 1:8, neonatal titer ≥1:32)¶;”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Congenital Syphilis
“a serum quantitative nontreponemal serologic titer equal to or less than fourfold of the maternal titer at delivery (e.g., maternal titer = 1:8, neonatal titer ≤1:16)”
Citations
Cites
Items 601–800 of 1,461
Scabies in healthcare settings.
Bouvresse, S., & Chosidow, O. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328336821b · Cited by 96
(2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6517a5 · Cited by 96
Vodstrcil, L. A., Walker, S. M., Hocking, J. S., Law, M., Forcey, D. S., Fehler, G., Bilardi, J. E., Chen, M. Y., Fethers, K. A., Fairley, C. K., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu1130 · Cited by 96
Fihn, S. D., Boyko, E. J., Normand, E. H., Chen, C.-L., Grafton, J. R., Hunt, M., Yarbro, P., Scholes, D., & Stergachis, A. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008958 · Cited by 96
The Traditional or Reverse Algorithm for Diagnosis of Syphilis: Pros and Cons
Ortiz, D. A., Shukla, M. R., & Loeffelholz, M. J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa307 · Cited by 96
Fan, H., Gilbert, R. E., O'Callaghan, F. J., & Li, L. (2020) · BMJ · doi:10.1136/bmj.m331 · Cited by 96
Longitudinal studies on chlamydial infections in the first year of life
Hammerschlag, M. R., Chandler, J. W., Alexander, E. R., ENGLISH, M., & Koutsky, L. A. (1982) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198211000-00007 · Cited by 95
High rates of syphilis among STI patients are contributing to the spread of HIV-1 in India.
Reynolds, S. J., Risbud, A. R., Shepherd, M. E., Rompalo, A. M., Ghate, M. V., Godbole, S. V., Joshi, S. N., Divekar, A. D., Gangakhedkar, R. R., Bollinger, R. C., et al. (2006) · Sexually Transmitted Infections · doi:10.1136/sti.2005.015040 · Cited by 95
Simms, I., Field, N., Jenkins, C., Childs, T., Gilbart, V. L., Dallman, T. J., Mook, P., Crook, P. D., & Hughes, G. (2015) · Eurosurveillance · doi:10.2807/1560-7917.es2015.20.15.21097 · Cited by 95
Estimates of the Prevalence and Incidence of Chlamydia and Gonorrhea Among US Men and Women, 2018
Kreisel, K. M., Weston, E. J., Cyr, S. B. S., & Spicknall, I. H. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001382 · Cited by 95
Bradshaw, C. S., Walker, J., Fairley, C. K., Chen, M. Y., Tabrizi, S. N., Donovan, B., Kaldor, J. M., McNamee, K., Urban, E., Walker, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057688 · Cited by 95
Delany-Moretlwe, S., Lombard, C., Baron, D., Bekker, L.-G., Nkala, B., Ahmed, K., Sebe, M., Brumskine, W., Nchabeleng, M., Palanee-Philips, T., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30428-6 · Cited by 95
Huppert, J. S., Mortensen, J. E., Reed, J. L., Kahn, J. A., Rich, K. D., & Hobbs, M. M. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31815abac6 · Cited by 94
Bodsworth, N. J., Crooks, R. J., Borelli, S., Vejlsgaard, G., Paavonen, J., Worm, A. M., Uexkull, N., Esmann, J., Strand, A., Ingamells, A. J., et al. (1997) · Sexually Transmitted Infections · doi:10.1136/sti.73.2.110 · Cited by 94
Glick, J. L., Theall, K. P., Andrinopoulos, K. M., & Kendall, C. (2018) · LGBT Health · doi:10.1089/lgbt.2017.0093 · Cited by 94
2015 UK National Guideline on the management of non-gonococcal urethritis
Horner, P., Blee, K., O’Mahony, C., Muir, P., Evans, C., & Radcliffe, K. W. (2015) · International Journal of STD & AIDS · doi:10.1177/0956462415586675 · Cited by 94
Eisenberg, M. (2001) · Archives of Sexual Behavior · doi:10.1023/a:1011958816438 · Cited by 94
Do women use dental dams? Safer sex practices of lesbians and other women who have sex with women
Richters, J., Prestage, G., Schneider, K., & Clayton, S. (2010) · Sexual Health · doi:10.1071/sh09072 · Cited by 94
Jones, J., Weiss, K., Mermin, J., Dietz, P., Rosenberg, E. S., Gift, T. L., Chesson, H., Sullivan, P. S., Lyles, C., Bernstein, K. T., et al. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000980 · Cited by 94
Changing patterns of disseminated gonococcal infection in France: cross-sectional data 2009–2011
Belkacem, A., Caumes, É., Ouanich, J., et al. (2013) · Sexually Transmitted Infections · doi:10.1136/sextrans-2013-051119 · Cited by 93
Flagg, E. W., Schwartz, R., & Weinstock, H. (2013) · American Journal of Public Health · doi:10.2105/ajph.2012.301182 · Cited by 93
Bjartling, C., OSSER, S., & Persson, K. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.02.036 · Cited by 93
Leli, C., Mencacci, A., Latino, M. A., et al. (2017) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2017.05.004 · Cited by 93
Tenofovir gel for the prevention of herpes simplex virus Type 2 infection.
Abdool Karim, S. S., Abdool Karim, Q., Kharsany, A. B. M., Baxter, C., Grobler, A. C., Werner, L., Kashuba, A., Mansoor, L. E., Samsunder, N., Mindel, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410649 · Cited by 92
The association between Mycoplasma genitalium and HIV-1 acquisition in African women
Napierala, S., Pol, B. J. V. D., Weiss, H. A., Kwok, C., Mambo, F., Chipato, T., van der Straten, A., Salata, R., & MORRISON, C. S. (2011) · AIDS · doi:10.1097/qad.0b013e32834ff690 · Cited by 92
de Vries, H. J. C., Zingoni, A., White, J. A., Ross, J. D. C., & Kreuter, A. (2013) · International Journal of STD & AIDS · doi:10.1177/0956462413516100 · Cited by 92
Risks for Acquisition of Bacterial Vaginosis Among Women Who Report Sex with Women: A Cohort Study
Marrazzo, J. M., Thomas, K. K., Fiedler, T. L., Ringwood, K., & Fredricks, D. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011139 · Cited by 92
Sexual Transmission During the Incubation Period of Primary HIV Infection
Pilcher, C. D., Eron, J. J., Vemazza, P. L., et al. (2001) · JAMA · doi:10.1001/jama.286.14.1713 · Cited by 92
Wald, A., Selke, S., Warren, T. J., Aoki, F. Y., Sacks, S. L., Díaz‐Mitoma, F., & Corey, L. (2006) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000204723.15765.91 · Cited by 92
Barbee, L. A., Khosropour, C. M., Dombrowksi, J. C., & Golden, M. R. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000614 · Cited by 92
Sh, E., Gl, O., & Smith, G. H. (1981) · PubMed · Cited by 92
Otosyphilis: A review of 85 cases
Yimtae, K., Srirompotong, S., & Lertsukprasert, K. (2007) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2006.08.026 · Cited by 92
Brenick, A., Romano, K., Kegler, C., & Eaton, L. A. (2017) · LGBT Health · doi:10.1089/lgbt.2016.0083 · Cited by 92
Sánchez, S. E., Garcia, P. J., Thomas, K. K., Catlin, M., & Holmes, K. K. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.06.089 · Cited by 92
Alexander, S., Ison, C., Parry, J., Llewellyn, C., Wayal, S., Richardson, D., Phillips, A., Smith, H., Fisher, M., & on behalf of the Brighton Home Sampling Kits Steering Group (2008) · Sexually Transmitted Infections · doi:10.1136/sti.2008.031443 · Cited by 92
HIV Infection as a Risk Factor for Shigellosis1
Baer, J. T., Vugia, D. J., Reingold, A. L., Aragon, T., Angulo, F. J., & Bradford, W. Z. (1999) · Emerging infectious diseases · doi:10.3201/eid0506.990614 · Cited by 91
Cu‐Uvin, S., Ko, H., Jamieson, D. J., Hogan, J. W., Schuman, P., Anderson, J., Klein, R. S., & HIV Epidemiology Research Study (HERS) Group (2002) · Clinical Infectious Diseases · doi:10.1086/340264 · Cited by 91
Haemophilus ducreyi Associated with Skin Ulcers among Children, Solomon Islands
Marks, M., Chi, K.-H., Vahi, V., et al. (2014) · Emerging infectious diseases · doi:10.3201/eid2010.140573 · Cited by 91
Bevan, C., Ridgway, G. L., & Rothermel, C. D. (2003) · Journal of International Medical Research · doi:10.1177/147323000303100108 · Cited by 91
Fethers, K., Twin, J., Fairley, C. K., Fowkes, F. J. I., Garland, S. M., Fehler, G., Morton, A. M., Hocking, J. S., Tabrizi, S. N., & Bradshaw, C. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030633 · Cited by 90
The HPTN 024 Study: The efficacy of antibiotics to prevent chorioamnionitis and preterm birth
Goldenberg, R. L., Mwatha, A., Read, J. S., Adeniyi‐Jones, S., Sinkala, M., Msmanga, G., Martinson, F. E. A., Hoffman, I., Fawzi, W. W., VALENTINE, M. E., et al. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.01.004 · Cited by 90
Ness, R. B., Randall, H. W., Richter, H. E., Peipert, J. F., Montagno, A. B., Soper, D. E., Sweet, R. L., Nelson, D. B., Schubeck, D., Hendrix, S. L., et al. (2004) · American Journal of Public Health · doi:10.2105/ajph.94.8.1327 · Cited by 90
Dombrowski, J. C., Wierzbicki, M. R., Newman, L. M., Powell, J. A., Miller, A. N., Dithmer, D., Soge, O. O., & Mayer, K. H. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab153 · Cited by 90
Identifying low-risk beta-lactam allergy patients in a UK tertiary centre.
Siew, L. Q. C., Li, P. H., Watts, T. J., Thomas, I., Ue, K. L., Caballero, M. R., Rutkowski, K., Till, S. J., Pillai, P., & Haque, R. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.03.015 · Cited by 89
Frølund, M., Lidbrink, P., Wikström, A., Cowan, S., Ahrens, P., & Jensen, J. (2016) · Acta Dermato Venereologica · doi:10.2340/00015555-2314 · Cited by 89
Treatment of Acute Pelvic Inflammatory Disease
Sweet, R. L. (2011) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2011/561909 · Cited by 89
Marrazzo, J. M., Dombrowski, J. C., Wierzbicki, M. R., Perlowski, C., Pontius, A., Dithmer, D., & Schwebke, J. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy554 · Cited by 89
Influence of Human Immunodeficiency Virus Infection on Pelvic Inflammatory Disease
Irwin, K. L., Moorman, A. C., O’Sullivan, M. J., SPERLING, R. S., KOESTLER, M. E., Soto, I., RICE, R. J., Brodman, M. L., Yasin, S. Y., Droese, A. L., et al. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(99)00621-3 · Cited by 89
Kissinger, P., Schmidt, N., Mohammed, H., Leichliter, J. S., Gift, T. L., Meadors, B., Sanders, C., & Farley, T. A. (2006) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000204511.84485.4c · Cited by 89
Feminizing genital gender-confirmation surgery.
Hadj-Moussa, M., Ohl, D. A., & Kuzon, W. M. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.11.005 · Cited by 89
Disseminated Gonococcal Infections in Patients Receiving Eculizumab: A Case Series
Crew, P. E., Abara, W. E., McCulley, L. V., Waldron, P. E., Kirkcaldy, R. D., Weston, E. J., Bernstein, K. T., Jones, S. C., & Bersoff‐Matcha, S. J. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy958 · Cited by 88
Cohen, S. E., Chew Ng, R. A., Katz, K. A., Bernstein, K. T., Samuel, M. C., Kerndt, P. R., & Bolan, G. (2012) · American Journal of Public Health · doi:10.2105/ajph.2011.300383 · Cited by 88
Golden, M. R., Morrow, R. A., Swenson, P. D., Hogrefe, W. R., Handsfield, H. H., & Wald, A. (2005) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000175377.88358.f3 · Cited by 88
Scratching the itch: new tools to advance understanding of scabies
Mounsey, K. E., McCarthy, J. S., & Walton, S. F. (2012) · Trends in Parasitology · doi:10.1016/j.pt.2012.09.006 · Cited by 88
DiClemente, R. J., Davis, T. L., Swartzendruber, A. L., Fasula, A. M., Boyce, L. S., Gelaude, D., Gray, S. C., Hardin, J. W., Rose, E., Carry, M., et al. (2014) · Women & Health · doi:10.1080/03630242.2014.932893 · Cited by 88
Providers should discuss U=U with all patients living with HIV.
Calabrese, S. K., & Mayer, K. H. (2019) · The Lancet HIV · doi:10.1016/s2352-3018(19)30030-x · Cited by 88
Interventions for trichomoniasis in pregnancy
Gülmezoglu, A. M., & Azhar, M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000220.pub2 · Cited by 88
Francis, S. C., Kent, C. K., Klausner, J. D., Rauch, L., Kohn, R., Hardick, A., & Gaydos, C. A. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318177ec39 · Cited by 87
Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia
Y. Chen, M., Stevens, K., Tideman, R., Zaia, A., Tomita, T., Fairley, C. K., Lahra, M., Whiley, D., & Hogg, G. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt017 · Cited by 87
Are Cephalosporins Safe for Use in Penicillin Allergy without Prior Allergy Evaluation?
Macy, E. M., & Blumenthal, K. G. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.07.033 · Cited by 86
Acyclovir Suppression to Prevent Recurrent Genital Herpesat Delivery
Scott, L. L., Hollier, L. M., McIntire, D., Sanchez, P. J., Jackson, G. L., & Wendel, G. D. (2002) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/s1064744902000054 · Cited by 86
Chronic Chlamydia trachomatis infections in infants.
Bell, T. A., Stamm, W. E., Wang, S. P., et al. (1992) · PubMed · Cited by 86
Aurelius, E., Franzen-Rohl, E., Glimaker, M., Akre, O., Grillner, L., Jorup-Ronstrom, C., Studahl, M., & the HSV-2 Meningitis Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis031 · Cited by 86
Campbell, L., Woods, V., Lloyd, T., Elsayed, S., & Church, D. L. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00671-08 · Cited by 86
Bachmann, L. H., Kirkcaldy, R. D., Geisler, W. M., Wiesenfeld, H. C., Manhart, L. E., Taylor, S. N., Seña, A. C., McNeil, C. J., Newman, L. M., Myler, N., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa293 · Cited by 86
Self-citationWiesenfeld, H. C., Meyn, L. A., Darville, T. L., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa101 · Cited by 86
Giannou, F. K., Tsiara, C. G., Nikolopoulos, G. K., Talias, M., Benetou, V., Kantzanou, M., Bonovas, S., & Hatzakis, A. (2016) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2016.1102635 · Cited by 85
Sena, A. C., Lensing, S., Rompalo, A. M., Taylor, S. N., Martin, D. H., Lopez, L. M., Lee, J. Y., & Schwebke, J. R. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis356 · Cited by 85
Itravenous desensitization to beta-lactam antibiotics
Borish, L., Tamir, R., & Rosenwasser, L. J. (1987) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(87)90037-6 · Cited by 85
Cervical Cancer Screening Among Women Without a Cervix
Sirovich, B. E. (2004) · JAMA · doi:10.1001/jama.291.24.2990 · Cited by 85
Mehta, S. D. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3182631d89 · Cited by 85
Barbee, L. A., Dombrowski, J. C., Kerani, R., & Golden, M. R. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000093 · Cited by 85
Barbee, L. A., Dhanireddy, S., Tat, S. A., & Marrazzo, J. M. (2015) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000320 · Cited by 85
Martin, I. E., Gu, W., Yang, Y., & Tsang, R. S. W. (2009) · Clinical Infectious Diseases · doi:10.1086/600878 · Cited by 85
Ohmit, S. E., Sobel, J. D., Schuman, P. C., Duerr, A. C., Mayer, K. H., Rompalo, A. M., & Klein, R. S. (2003) · The Journal of Infectious Diseases · doi:10.1086/375746 · Cited by 84
Control of Smoke From Laser/Electric Surgical Procedures
(1999) · Applied Occupational and Environmental Hygiene · doi:10.1080/104732299303205 · Cited by 84
Standards for Health Information Technology to Ensure Adolescent Privacy
Blythe, M. J., Adelman, W. P., Breuner, C. C., Levine, D. A., Marcell, A. V., Murray, P. J., O’Brien, R. F., Beccaro, M. A. D., Schneider, J. H., Weinberg, S. T., et al. (2012) · PEDIATRICS · doi:10.1542/peds.2012-2580 · Cited by 84
Louie, K. S., Castellsagué, X., de Sanjosé, S., Herrero, R., Meijer, C. J. L. M., Shah, K. V., Muñóz, N., & Bosch, F. X. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0284 · Cited by 84
Serosorting is associated with a decreased risk of HIV seroconversion in the EXPLORE Study Cohort.
Philip, S. S., Yu, X., Donnell, D., Vittinghoff, E., & Buchbinder, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012662 · Cited by 84
Bjartling, C., OSSER, S., & Persson, K. (2010) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02455.x · Cited by 84
Manhart, L. E., Khosropour, C. M., Liu, C., Gillespie, C. W., Depner, K., Fiedler, T. L., Marrazzo, J. M., & Fredricks, D. N. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000054 · Cited by 83
Mayer, K. H., Bush, T., Henry, K., Overton, E. T., Hammer, J., Richardson, J., Wood, K., Conley, L., Papp, J., Caliendo, A. M., et al. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31823b1922 · Cited by 83
Morris, B. J., Hankins, C. A., Banerjee, J., Lumbers, E. R., Mindel, A., Klausner, J. D., & Krieger, J. N. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00004 · Cited by 83
Zetola, N. M., Bernstein, K. T., Wong, E., Louie, B., & Klausner, J. D. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318195bd2b · Cited by 83
Skin testing and oral penicillin challenge in patients with a history of remote penicillin allergy.
Goldberg, A., & Confino-Cohen, R. (2008) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)60402-4 · Cited by 83
Ghinai, R., El‐Duah, P., Chi, K.-H., Pillay, A., Solomon, A. W., Bailey, R. L., Agana, N., Mabey, D. C. W., Chen, C., Adu‐Sarkodie, Y., et al. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003496 · Cited by 82
Perkins, R. B., Guido, R. L., Saraiya, M., Sawaya, G. F., Wentzensen, N., Schiffman, M., & Feldman, S. (2021) · Journal of Women's Health · doi:10.1089/jwh.2020.8918 · Cited by 82
Douching and Endometritis: Results From the PID Evaluation and Clinical Health (PEACH) Study
NESS, R. B., SOPER, D. E., HOLLEY, R. L., PEIPERT, J., RANDALL, H., SWEET, R. L., SONDHEIMER, S. J., HENDRIX, S. L., HILLIER, S. L., AMORTEGUI, A., et al. (2001) · Sex Transm Dis · doi:10.1097/00007435-200104000-00010 · Cited by 82
Hilbert, D. W., Smith, W. L., Chadwick, S. G., Toner, G., Mordechai, E., Adelson, M. E., Aguin, T. J., Sobel, J. D., & Gygax, S. E. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.03104-15 · Cited by 82
Scabies: a neglected global disease.
Leung, A. K. C., Lam, J. M., & Leong, K. F. (2020) · Current Pediatric Reviews · doi:10.2174/1573396315666190717114131 · Cited by 82
Carter, J. E., & Whithaus, K. C. (2008) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2008.78.17 · Cited by 82
Theeten, H., Van Herck, K., Van Der Meeren, O., Crasta, P., Van Damme, P., & Hens, N. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.008 · Cited by 82
Kong, F. Y. S., Horner, P., Unemo, M., & Hocking, J. S. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky548 · Cited by 82
Muratani, T., Akasaka, S., Kobayashi, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3603-3606.2001 · Cited by 82
Bradshaw, C. S., Walker, S. M., Vodstrcil, L. A., Bilardi, J. E., Law, M., Hocking, J. S., Fethers, K. A., Fehler, G., Petersen, S., Tabrizi, S. N., et al. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jit664 · Cited by 82
Female-to-female transmission of human immunodeficiency virus.
Kwakwa, H. A., & Ghobrial, M. W. (2003) · Clinical Infectious Diseases · doi:10.1086/345462 · Cited by 81
Brouwer, A. F., Delinger, R. L., Eisenberg, M. C., et al. (2019) · BMC Public Health · doi:10.1186/s12889-019-7134-1 · Cited by 81
Male non‐gonococcal urethritis: From microbiological etiologies to demographic and clinical features
Ito, S., Hanaoka, N., Shimuta, K., Seike, K., Tsuchiya, T., Yasuda, M., Yokoi, S., Nakano, M., Ohnishi, M., & Deguchi, T. (2016) · International Journal of Urology · doi:10.1111/iju.13044 · Cited by 81
A Brief History of Evolving Diagnostics and Therapy for Gonorrhea: Lessons Learned
Hook, E. W., & Kirkcaldy, R. D. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy271 · Cited by 81
Detection and Quantification of Mycoplasma genitalium in Male Patients with Urethritis
Dupin, N., Bijaoui, G., Schwarzinger, M., Ernault, P., Gerhardt, P., Jdid, R., Hilab, S., Pantoja, C., Buffet, M., Escande, J.-P., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376990 · Cited by 81
Cerebrospinal fluid reference values for young infants undergoing lumbar puncture.
Thomson, J., Sucharew, H., Cruz, A. T., Nigrovic, L. E., Freedman, S. B., Garro, A. C., Balamuth, F., Mistry, R. D., Arms, J. L., Ishimine, P. T., et al. (2018) · Pediatrics · doi:10.1542/peds.2017-3405 · Cited by 81
Seña, A. C., Bachmann, L. H., & Hobbs, M. M. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.887440 · Cited by 81
Self-citation(1996) · PubMed · Cited by 80
(2016) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2015.12.009 · Cited by 80
Jones, M. L. J., Chapin-Bardales, J., Bizune, D. J., Papp, J. R., Phillips, C., Kirkcaldy, R. D., Wejnert, C., Bernstein, K. T., National HIV Behavioral Surveillance Sexually Transmitted Infection Study Group, National HIV Behavioral Surveillance Sexually Transmitted Infection Study Group, et al. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6814a1 · Cited by 80
Maternal and Neonatal Herpes Simplex Virus Infections
Pinninti, S. G., & Kimberlin, D. W. (2013) · American Journal of Perinatology · doi:10.1055/s-0032-1332802 · Cited by 80
HIV testing among transgender women and men—27 states and Guam, 2014–2015.
Pitasi, M. A., Oraka, E., Clark, H., Town, M., & DiNenno, E. A. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6633a3 · Cited by 79
Pinninti, S. G., Angara, R., Feja, K. N., Kimberlin, D. W., Leach, C. T., Conrad, D. A., McCarthy, C. A., & Tolan, R. W. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.12.053 · Cited by 79
Wong, T., Singh, A. E., & De, P. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.04.042 · Cited by 79
Hiroi, H., Yasugi, T., Matsumoto, K., Fujii, T., Watanabe, T., Yoshikawa, H., & Taketani, Y. (2001) · Journal of Surgical Oncology · doi:10.1002/jso.1067 · Cited by 79
Barberá, M.-J., Fernández-Huerta, M., Jensen, J.-S., Caballero, E., & Andreu, A. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000631 · Cited by 78
Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection
Li, Y., Le, W.-J., Li, S., Cao, Y.-P., & Su, X.-H. (2017) · International Journal of STD & AIDS · doi:10.1177/0956462416688562 · Cited by 78
Danby, C. S., Cosentino, L. A., Rabe, L. K., Priest, C. L., Damare, K. C., Macio, I. S., Meyn, L. A., Wiesenfeld, H. C., & Hillier, S. L. (2016) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000384 · Cited by 78
MERTZ, G. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.3.343 · Cited by 78
Jacobson, G. F., Autry, A. M., Kirby, R. S., Liverman, E. M., & Motley, R. U. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.115050 · Cited by 78
Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses.
Wood, B. A., & Monro, A. M. (1975) · Sexually Transmitted Infections · doi:10.1136/sti.51.1.51 · Cited by 78
Association of Recent Bacterial Vaginosis With Acquisition of Mycoplasma genitalium
Lokken, E. M., Balkus, J. E., Kiarie, J. N., Hughes, J. P., Jaoko, W. G., Totten, P. A., McClelland, R. S., & Manhart, L. E. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx043 · Cited by 78
Distribution of Genital Lactobacillus Strains Shared by Female Sex Partners
Marrazzo, J. M., Antonio, M., Agnew, K., & Hillier, S. L. (2009) · Journal of Infectious Diseases · doi:10.1086/596632 · Cited by 78
Rapues, J., Wilson, E. C., Packer, T., Colfax, G. N., & Raymond, H. F. (2013) · American Journal of Public Health · doi:10.2105/ajph.2012.301109 · Cited by 77
Ceftibuten Resistance and Treatment Failure ofNeisseria gonorrhoeaeInfection
Lo, J. Y. C., Ho, K., Leung, A. O. C., Tiu, F. S. T., Tsang, G. K. L., Lo, A. C. T., & TAPSALL, J. W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00198-08 · Cited by 77
Treatment of Chlamydial Pneumonia of Infancy
Beem, M. O., Saxon, E. M., & Tipple, M. A. (1979) · PEDIATRICS · doi:10.1542/peds.63.2.198 · Cited by 77
Chronic Chlamydia trachomatis infections in infants.
Bell, T. A. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480030078041 · Cited by 77
Shigellosis linked to sex venues, Australia.
O'Sullivan, B., Delpech, V., Pontivivo, G., Karagiannis, T., Marriott, D., Harkness, J., & McAnulty, J. M. (2002) · Emerging infectious diseases · doi:10.3201/eid0808.010534 · Cited by 77
Duerr, A. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02729-1 · Cited by 77
Treatment of neurosyphilis with ceftriaxone.
Shann, S. (2003) · Sexually Transmitted Infections · doi:10.1136/sti.79.5.415 · Cited by 76
Oldenburg, C. E., Nunn, A. S., Montgomery, M., Almonte, A., Mena, L., Patel, R. R., Mayer, K. H., & Chan, P. A. (2018) · AIDS and Behavior · doi:10.1007/s10461-017-1701-1 · Cited by 76
Self-citationWho needs penicillin allergy testing?
Macy, E., & Vyles, D. (2018) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2018.07.041 · Cited by 76
Difficult‐to‐Treat Trichomoniasis: Results with Paromomycin Cream
Nyirjesy, P., Sobel, J. D., Weitz, M. V., Leaman, D., & Gelone, S. P. (1998) · Clinical Infectious Diseases · doi:10.1086/513951 · Cited by 76
Dionne-Odom, J., Geisler, W. M., Aaron, K. J., Waites, K. B., Westfall, A. O., Van Der Pol, B., & Xiao, L. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix853 · Cited by 76
Rates of and Risk Factors for Trichomoniasis Among Pregnant Inmates in New York City
SHUTER, J., BELL, D., GRAHAM, D., HOLBROOK, K. A., & BELLIN, E. Y. (1998) · Sexually Transmitted Diseases · doi:10.1097/00007435-199807000-00006 · Cited by 76
Plummer, E. L., Vodstrcil, L. A., Danielewski, J., Murray, G. L., Fairley, C. K., Garland, S. M., Hocking, J. S., Tabrizi, S. N., & Bradshaw, C. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190199 · Cited by 75
Morrow, R. A., Friedrich, D. A., Meier, A. S., & Corey, L. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-84 · Cited by 75
Doshani, M., Weng, M., Moore, K. L., Romero, J. R., & Nelson, N. P. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6806a6 · Cited by 75
Do sexual minorities receive appropriate sexual and reproductive health care and counseling?
Everett, B. G., Higgins, J. A., Haider, S., & Carpenter, E. (2019) · Journal of Women s Health · doi:10.1089/jwh.2017.6866 · Cited by 75
Association between sexually transmitted diseases and young adults’ self-reported abstinence.
DiClemente, R. J., Sales, J. M., Danner, F., & Crosby, R. A. (2011) · PEDIATRICS · doi:10.1542/peds.2009-0892 · Cited by 74
Koh, A. S., Gómez, C. A., Shade, S., & Rowley, E. (2005) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000175417.17078.21 · Cited by 74
WEST, B., MORISON, L., VAN DER LOEFF, M. S., GOODING, E., AWASANA, A. A., DEMBA, E., & MAYAUD, P. (2003) · Sexually Transmitted Diseases · doi:10.1097/00007435-200306000-00003 · Cited by 74
Sexual transmission of hepatitis C virus among gay and bisexual men: a systematic review.
Jin, F., Matthews, G. V., & Grulich, A. E. (2017) · Sexual Health · doi:10.1071/sh16141 · Cited by 74
Smith, N. H., Musher, D. M., Huang, D. B., Rodriguez, P. S., Dowell, M. E., Ace, W., & White, A. C. (2004) · International Journal of STD & AIDS · doi:10.1177/095646240401500511 · Cited by 74
Preterm labor and bacterial vaginosis-associated bacteria among urban women
Nelson, D. B., Hanlon, A. L., Hassan, S., Britto, J., Geifman-Holtzman, O., Haggerty, C. L., & Fredricks, D. N. (2008) · Journal of Perinatal Medicine · doi:10.1515/jpm.2009.026 · Cited by 74
DiOrio, D., Kroeger, K., & Ross, A. (2018) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000783 · Cited by 73
Lesbians and cervical screening.
(2000) · Europe PMC (PubMed Central) · Cited by 73
Letter: Shigella enteritis venereally transmitted.
Dritz, S. K., & Back, A. F. (1974) · PubMed · Cited by 73
Muzny, C. A., Sunesara, I. R., Martin, D. H., & Mena, L. A. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31822e6179 · Cited by 73
Self-citationAssociation between male circumcision and women’s biomedical health outcomes: a systematic review.
Grund, J. M., Bryant, T. S., Jackson, I., Curran, K., Bock, N., Toledo, C., Taliano, J., Zhou, S., del Campo, J. M., Yang, L., et al. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30369-8 · Cited by 73
Legere, H. J., Palis, R. I., Bouza, T. R., Uluer, A. Z., & Castells, M. C. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.08.002 · Cited by 73
Predicting chlamydial and gonococcal cervical infection: implications for management of cervicitis
Marrazzo, J. M., Handsfield, H. H., & Whittington, W. L. H. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02140-3 · Cited by 73
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Donahue, K., Doubeni, C. A., Epling, J. W., et al. (2020) · JAMA · doi:10.1001/jama.2020.2684 · Cited by 73
Barbee, L. A., Khosropour, C. M., Dombrowski, J. C., Manhart, L. E., & Golden, M. R. (2016) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052214 · Cited by 72
Suk, R., Mahale, P. S., Sonawane, K., Sikora, A. G., Chhatwal, J., Schmeler, K. M., Sigel, K. M., Cantor, S. B., Chiao, E. Y., & Deshmukh, A. A. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.1999 · Cited by 71
McCaffery, K. J., Irwig, L., Turner, R. M., Chan, S. F., Macaskill, P., Lewicka, M., Clarke, J., Weisberg, E., & Barratt, A. L. (2010) · BMJ · doi:10.1136/bmj.b4491 · Cited by 71
Towns, J. M., Leslie, D. E., Denham, I., Azzato, F., Fairley, C. K., & Chen, M. (2016) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052219 · Cited by 71
The Use of Metronidazole During Pregnancy: A Review of Evidence
Sheehy, O., dos Santos, F. F. T., Ferreira, E., et al. (2015) · Current Drug Safety · doi:10.2174/157488631002150515124548 · Cited by 71
Wind, C. M., de Vries, E., van der Loeff, M. F. S., van Rooijen, M. S., van Dam, A. P., Demczuk, W., Martín, I., & de Vries, H. J. C. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix249 · Cited by 71
BLANK, S., McDONNELL, D. D., RUBIN, S. R., NEAL, J. J., BROME, M. W., MASTERSON, M. B., & GREENSPAN, J. R. (1997) · Sexually Transmitted Diseases · doi:10.1097/00007435-199704000-00006 · Cited by 71
Laxmi, U., Agrawal, S., Raghunandan, C., Randhawa, V. S., & Saili, A. (2011) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2011.565390 · Cited by 71
A review of the effectiveness and acceptability of the female condom for dual protection
Gallo, M. F., Kilbourne‐Brook, M., & Coffey, P. S. (2012) · Sexual Health · doi:10.1071/sh11037 · Cited by 70
Screen more or screen more often? Using mathematical models to inform syphilis control strategies.
Tuite, A. R., Fisman, D. N., & Mishra, S. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-606 · Cited by 70
Solensky, R., Jacobs, J., Lester, M., Lieberman, P., McCafferty, F., Nilsson, T., Park, M., Schwarz, G., Soong, W., Wagelie-Steffen, A., et al. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.02.040 · Cited by 70
Preterm labour--is bacterial vaginosis involved?
Odendaal, H. J., Popov, I., Schoeman, J. C., Smith, M. A., & Grove, D. (2002) · PubMed · Cited by 70
HIV, STD, and hepatitis risk behaviors of young men before and after incarceration
Morrow, K. M., & the Project START Study Group (2009) · AIDS Care · doi:10.1080/09540120802017586 · Cited by 70
Masese, L., Baeten, J. M., Richardson, B. A., Bukusi, E., John-Stewart, G., Graham, S. M., Shafi, J., Kiarie, J., Overbaugh, J., & McClelland, R. S. (2015) · AIDS · doi:10.1097/qad.0000000000000646 · Cited by 70
Meaningful Use of a Confidential Adolescent Patient Portal
Thompson, L. A., Martinko, T., Budd, P. R., Mercado, R., & Schentrup, A. M. (2016) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2015.10.015 · Cited by 70
Sena, A. C., Wolff, M., Behets, F., Van Damme, K., Martin, D. H., Leone, P., McNeil, L., & Hook, E. W. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis918 · Cited by 69
McDanel, D. L., Azar, A. E., Dowden, A. M., Murray-Bainer, S., Noiseux, N. O., Willenborg, M., Clark, C. R., Callaghan, J. J., & Haleem, A. (2017) · The Journal of Arthroplasty · doi:10.1016/j.arth.2017.01.012 · Cited by 69
'Shelf life' of Trichomonas vaginalis
Kingston, M., Bansal, D., & Carlin, E. M. (2003) · International Journal of STD & AIDS · doi:10.1258/095646203321043228 · Cited by 69
Singh, D., Fine, D. N., & Marrazzo, J. M. (2011) · American Journal of Public Health · doi:10.2105/ajph.2009.169631 · Cited by 69
Advances in the Understanding and Treatment of Male Urethritis
Bachmann, L. H., Manhart, L. E., Martin, D. H., Seña, A. C., Dimitrakoff, J. D., Jensen, J. S., & Gaydos, C. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ755 · Cited by 69
Self-citationInterventions for treating scabies
Munn, Z. (2008) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2008.04675.x · Cited by 69
Prevalence and risk factors for infection with herpes simplex virus type-1 and -2 among lesbians.
Marrazzo, J. M., Stine, K., & Wald, A. (2003) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000091151.52656.e5 · Cited by 69
Koedijk, F. D. H., van Bergen, J. E. A. M., Dukers-Muijrers, N. H. T. M., van Leeuwen, A. P., Hoebe, C. J. P. A., & van der Sande, M. A. B. (2012) · International Journal of STD & AIDS · doi:10.1258/ijsa.2012.011378 · Cited by 69
Mehta, S. D., Moses, S., Parker, C. B., Agot, K., Maclean, I., & Bailey, R. C. (2012) · AIDS · doi:10.1097/qad.0b013e328352d116 · Cited by 69
Henderson, J. T., Senger, C. A., Henninger, M. L., Bean, S., Redmond, N., & O’Connor, E. (2020) · JAMA · doi:10.1001/jama.2020.10371 · Cited by 69
Jurstrand, M., Jensen, J. S., Magnuson, A., Kamwendo, F., & Fredlund, H. (2007) · Sexually Transmitted Infections · doi:10.1136/sti.2007.024752 · Cited by 69
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2019) · JAMA · doi:10.1001/jama.2019.9365 · Cited by 68
Interventions for emergency contraception
Shen, J., Che, Y., Showell, E., Chen, K., & Cheng, L. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001324.pub6 · Cited by 68
Natural history of chronic hepatitis B virus infection.
Busch, K., & Thimme, R. (2015) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0369-7 · Cited by 68
Risk Perceptions and Subsequent Sexual Behaviors After HPV Vaccination in Adolescents
Mayhew, A., Mullins, T. L. K., Ding, L., Rosenthal, S. L., Zimet, G. D., Morrow, C., & Kahn, J. A. (2014) · PEDIATRICS · doi:10.1542/peds.2013-2822 · Cited by 68
The real problem with male condoms is nonuse.
Steiner, M. J., Cates, W., & Warner, L. (1999) · Sexually Transmitted Diseases · doi:10.1097/00007435-199909000-00007 · Cited by 67
Lymphogranuloma Venereum in Men Screened for Pharyngeal and Rectal Infection, Germany
Haar, K., Dudareva, S., Wisplinghoff, H., Wisplinghoff, F., Sailer, A., Jansen, K., Henrich, B., & Marcus, U. (2013) · Emerging infectious diseases · doi:10.3201/eid1903.121028 · Cited by 67
HIV-2 Infection Surveillance--United States, 1987-2009.
(2011) · PubMed · Cited by 67
Progression of ultrasound findings of fetal syphilis after maternal treatment
Rac, M. W. F., Bryant, S. N., McIntire, D. D., Cantey, J. B., Twickler, D. M., Wendel, G. D., & Sheffield, J. S. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.05.049 · Cited by 67
Disseminated Gonococcal Infection in Women
Bleich, A. T., Sheffield, J. S., Wendel, G. D., et al. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318244eda9 · Cited by 67
Bazan, J. A., Peterson, A. S., Kirkcaldy, R. D., Briere, E. C., Maierhofer, C., Turner, A. N., Licon, D. B., Parker, N., Dennison, A., Ervin, M., et al. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6521a5 · Cited by 67
Trivedi, S., Williams, C., Torrone, E., & Kidd, S. (2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003000 · Cited by 67
Neurologic manifestations of podophyllin toxicity
Filley, C. M., Graff, C., Lacy, J. R., et al. (1982) · Neurology · doi:10.1212/wnl.32.3.308 · Cited by 67
Sexual assault victims: factors associated with follow-up care.
Ackerman, D. R., Sugar, N. F., Fine, D. N., & Eckert, L. O. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.03.014 · Cited by 67
Cancer Screening Among Jail Inmates: Frequency, Knowledge, and Willingness
Binswanger, I. A., White, M. C., Pérez‐Stable, E. J., Goldenson, J., & Tulsky, J. P. (2005) · American Journal of Public Health · doi:10.2105/ajph.2004.052498 · Cited by 66
Implementation of an infectious disease fellow-managed penicillin allergy skin testing service.
Heil, E. L., Bork, J. T., Schmalzle, S. A., Kleinberg, M., Kewalramani, A., Gilliam, B. L., & Buchwald, U. K. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw155 · Cited by 66
HOOK, E. W., BAKER-ZANDER, S. A., MOSKOVITZ, B. L., LUKEHART, S. A., & HANDSFIELD, H. H. (1986) · Sexually Transmitted Diseases · doi:10.1097/00007435-198607000-00018 · Cited by 66
(1993) · PubMed · Cited by 66
Radix, A. E., Lelutiu-Weinberger, C., & Gamarel, K. E. (2014) · LGBT Health · doi:10.1089/lgbt.2013.0042 · Cited by 66
Mimiaga, M. J., Mayer, K. H., Reisner, S. L., Gonzalez, A., Dumas, B., VanDerwarker, R., Novak, D. S., & Bertrand, T. E. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31816471ae · Cited by 65
Mycoplasma genitalium in Toronto, Ont: Estimates of prevalence and macrolide resistance.
Gesink, D., Racey, C. S., Seah, C., Zittermann, S. I., Mitterni, L., Juzkiw, J., Jamieson, H., Greer, J., Singh, S., Jensen, J. S., et al. (2016) · Europe PMC (PubMed Central) · Cited by 65
Li, Y., Su, X., Le, W., Li, S., Yang, Z., Chaisson, C. E., Madico, G. E., Gong, X., Reed, G. W., Wang, B., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz294 · Cited by 65
The etiology of infectious proctitis in men who have sex with men differs according to HIV status.
Bissessor, M., Fairley, C. K., Read, T., Denham, I., Bradshaw, C., & Chen, M. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000022 · Cited by 65
Hens, N., Habteab Ghebretinsae, A., Hardt, K., Van Damme, P., & Van Herck, K. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.10.088 · Cited by 65
Chlamydia muridarum enters a viable but non-infectious state in amoxicillin-treated BALB/c mice
Campbell, R. B. P., Kintner, J., Whittimore, J. D., & Schoborg, R. V. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.07.017 · Cited by 65
Invasive amebiasis in men who have sex with men, Australia.
Stark, D., van Hal, S. J., Matthews, G., Harkness, J., & Marriott, D. (2008) · Emerging infectious diseases · doi:10.3201/eid1407.080017 · Cited by 64
Dukers–Muijrers, N. H. T. M., Wolffs, P. F. G., de Vries, H. J. C., Götz, H. M., Heijman, T., Bruisten, S. M., Eppings, L., Hogewoning, A. A., Steenbakkers, M. W. H. L., Lucchesi, M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz050 · Cited by 64
Research works printed but not linked: 13
- Golden MR, Kerani RP, Stenger M, Effect of expedited partner therapy (EPT) on chlamydial prevalence: the Washington State Community-Level Trial. Presented at the STD Prevention Conference, Minneapolis, MN; March 12–15, 2012.
- Lin JS, Eder M, Bean S. Screening for syphilis infection in pregnant women: a reaffirmation evidence update for the U.S. Preventive Services Task Force. Evidence Synthesis No. 167. AHRQ Publication No. 18-05238-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2018. 30234936
- Benton S, Smith J, Wang F, Heitgerd J, Belcher L, Patel H. HIV testing, diagnosis, and linkage to care among persons tested in select CDC-funded health care and non-health care settings, 2012–2017. Presented at the National HIV Prevention Conference, Atlanta, GA: March 18–21, 2019.
- Briggs GC. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 11th ed. Philadelphia, PA: Wolters Kluwer; 2017.
- Blanco JL, Fuertes I, Bosch J, Effective treatment of lymphogranuloma venereum (LGV) with 1g azithormycin administered weekly for 3 weeks in HIV-infected population. Presented at the Conference on Retroviruses and Opportunist Infections, Seattle, WA; February 23–26, 2015.
- Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 · DOI · Paper page
- Ahmed KA, Fox SJ, Frigas E, Park MA. Clinical outcome in the use of cephalosporins in pediatric patients with a history of penicillin allergy. Int Arch Allergy Immunol 2012; 158: 405– 10. 10.1159/000333553 22487723 · DOI · Paper page
- Park IU, Chow JM, Bolan G, Stanley M, Shieh J, Schapiro JM. Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management. J Infect Dis 2011; 204: 1297– 304. 10.1093/infdis/jir524 21930610 · DOI · Paper page
- Muzny CA, Blackburn RJ, Sinsky RJ, Austin EL, Schwebke JR. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic. Clin Infect Dis 2014; 59: 834– 41. 10.1093/cid/ciu446 24928292 · DOI · Paper page
- Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis 2001; 33: 1341– 6. 10.1086/323034 11565074 · DOI · Paper page
- Perkins RB, Guido RS, Castle PE,; 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2020; 24: 102– 31. 10.1097/LGT.0000000000000525 32243307 PMC7147428 · DOI · Paper page
- Al Jaff DAA, Amin MHM. Comparison of the effectiveness of sulphur ointment, permethrin and oral ivermectin in treatment of scabies. Res J Pharm Biol Chem Sci 2018; 9: 670– 6.
- Chiu S, Argaez C. Ivermectin for parasitic skin infections of scabies: a review of comparative clinical effectiveness, cost-effectiveness, and guidelines. Ottawa, ON: Canadian Agency for Drugs and Technologies in Health; 2019. https://www.ncbi.nlm.nih.gov/books/NBK545083/ 31424718
Cited by
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., et al. (2022) · International Journal of Transgender Health · doi:10.1080/26895269.2022.2100644 · Cited by 2,698
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections
Luetkemeyer, A. F., Donnell, D., Dombrowski, J. C., Cohen, S., Grabow, C., Brown, C. E., Malinski, C., Perkins, R., Nasser, M., Lopez, C., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2211934 · Cited by 468
Towards a deeper understanding of the vaginal microbiota
France, M., Alizadeh, M., Brown, S., Ma, B., & Ravel, J. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01083-2 · Cited by 382
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gonzalez, M. D., Harrington, A., Jerris, R. C., Kehl, S. C., Leal, S. M., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae104 · Cited by 376
Diagnosis and Treatment of Sexually Transmitted Infections: A Review
Tuddenham, S., Hamill, M. M., & Ghanem, K. G. (2022) · JAMA · doi:10.1001/jama.2021.23487 · Cited by 302
Metadata
- Authors
- Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A.
- Affiliations
- Emory University (US)
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
- Brown University (US)
- University of Washington (US)
- University of Alabama at Birmingham (US)
- Johns Hopkins University (US)
- Washington University in St. Louis (US)
- Corresponding author
- Workowski, Kimberly A.
- ORCID
- Venue
- MMWR. Recommendations and Reports
- Published
- 2021-07-23
- Volume
- 70
- Issue
- 4
- Pages
- 1-187
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- PMC
- PMC8344968
- OpenAlex
- W3185444663
- Semantic Scholar
- eb300ecb7d38078ce65557d8188da1edbd3174fc
- Cited by
- 3,018
- References
- 1,505
- Citations by year
- 2026: 740 · 2025: 655 · 2024: 606 · 2023: 558 · 2022: 385 · 2021: 64
- FWCI
- 256.76
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- public-domain
- Locations
- MMWR Recommendations and Reports (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R25MH083620)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Keywords
- sexually transmitted infections, STI treatment, gonorrhea, Chlamydia trachomatis, Trichomonas vaginalis, pelvic inflammatory disease, bacterial vaginosis, Mycoplasma genitalium, HPV vaccine, HCV screening, HIV prevention
- MeSH terms
- Centers for Disease Control and Prevention, U.S., Humans, Sexually Transmitted Diseases, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
